Effect of polymyxin B sulfate on endotoxin activity in a gram-negative septicemia model
- PMID: 219410
- DOI: 10.1203/00006450-197901000-00011
Effect of polymyxin B sulfate on endotoxin activity in a gram-negative septicemia model
Abstract
The antiendotoxin effect of polymyxin B was investigated in experimentally induced septicemia in rabbits. The Pasteurella multocida organisms were sensitive to the antibacterial action of penicillin but not to polymyxin B. Animals pre-treated with polymyxin showed positive blood cultures and significantly reduced plasma endotoxin levels (Limulus test) with normal white blood cell and platelet counts when analyzed 6 hr after the injection of live organisms. Polymyxin therapy given after the animals had established septicemia-endotoxemia reduced the plasma endotoxin levels and improved the survival, but had no effect on the leukopenia and thrombocytopenia. The best survival data were obtained in rabbits who were treated with both penicillin and polymyxin. The data suggest that polymyxin is effective in neutralizing the endotoxic effects from live organisms and that the timing and perhaps duration of the polymyxin treatment is of critical importance. In addition, a modified Limulus lysate method was developed which showed that quantitative plasma endotoxin determination could be made more sensitive by prior heating of the plasma to remove the natural inhibitors.
Similar articles
-
In vivo effect of polymyxin B on pertussis vaccine.Am J Dis Child. 1984 Mar;138(3):281-3. doi: 10.1001/archpedi.1984.02140410059018. Am J Dis Child. 1984. PMID: 6322572
-
Polymyxin B moderates acidosis and hypotension in established, experimental gram-negative septicemia.J Infect Dis. 1987 Nov;156(5):706-12. doi: 10.1093/infdis/156.5.706. J Infect Dis. 1987. PMID: 2821123
-
Effect of heparin in experimental gram-negative septicemia.J Infect Dis. 1975 Feb;131(2):138-43. doi: 10.1093/infdis/131.2.138. J Infect Dis. 1975. PMID: 1117188
-
Polymyxin-B endotoxin removal device: making the point on mechanisms of action, clinical effectiveness and possible future applications: review.Infect Disord Drug Targets. 2013 Apr;13(2):128-32. doi: 10.2174/18715265113139990025. Infect Disord Drug Targets. 2013. PMID: 23919356 Review.
-
Novel therapies for sepsis: antiendotoxin therapies.Expert Opin Investig Drugs. 2002 Dec;11(12):1795-812. doi: 10.1517/13543784.11.12.1795. Expert Opin Investig Drugs. 2002. PMID: 12457439 Review.
Cited by
-
Endotoxemia: methods of detection and clinical correlates.Clin Microbiol Rev. 1995 Apr;8(2):268-92. doi: 10.1128/CMR.8.2.268. Clin Microbiol Rev. 1995. PMID: 7621402 Free PMC article. Review.
-
Inhibition of endotoxin-induced priming of human neutrophils by lipid X and 3-Aza-lipid X.J Clin Invest. 1987 Sep;80(3):605-12. doi: 10.1172/JCI113112. J Clin Invest. 1987. PMID: 3624479 Free PMC article.
-
Polymyxin B sulphate protects cats against the haemodynamic and metabolic effects of E. coli endotoxin.Br J Pharmacol. 1981 Nov;74(3):701-7. doi: 10.1111/j.1476-5381.1981.tb10481.x. Br J Pharmacol. 1981. PMID: 6170378 Free PMC article.
-
Protection against group B Neisseria meningitidis disease: effect of serogroup B polysaccharide and polymyxin B on immunogenicity of serotype protein preparations.Infect Immun. 1982 Jul;37(1):264-70. doi: 10.1128/iai.37.1.264-270.1982. Infect Immun. 1982. PMID: 6809628 Free PMC article.
-
Antibiotic-induced bacterial cell lysis: a therapeutic dilemma.Eur J Clin Microbiol. 1986 Feb;5(1):11-2. doi: 10.1007/BF02013453. Eur J Clin Microbiol. 1986. PMID: 2938943 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources